BSPK
Bespoke Extracts, Inc.Company Information
- Company Name
- Bespoke Extracts, Inc.
- CIK
- CIK0001409197
- Category
- <br>Emerging growth company
- Ticker: Exchange
- BSPK: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BSPK
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-09-11
- Last sale
- —
- Shares purchased (TTM)
- 27,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2020-03-31
- Institutional shares owned
- 1,000
- Shares outstanding
- 110,388,426
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2025-11-12
- Price on filing date
- —
- 1-month reaction
- 31.58%
- 3-month reaction
- 64.47%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash | - | - | - | 0 | - | - | 0 | 0 | - | - | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Furniture And Fixtures Gross | - | - | - | - | - | - | 0 | 0 | 0 | - | - | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | ||||||
| Finite Lived License Agreements Gross | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Notes Payable Related Parties Classified Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Bank Overdrafts | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 1 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Secured Debt Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Secured Long Term Debt | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Long Term Notes Payable | 0 | 0 | 0 | - | - | 1 | 1 | 1 | 1 | 1 | - | - | ||||||
| Operating Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 23 | 23 | 23 | ||||||
| Retained Earnings Accumulated Deficit | -27 | -27 | -27 | -26 | -26 | -26 | -26 | -25 | -25 | -25 | -24 | -24 | ||||||
| Stockholders Equity | -3 | -3 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series C Preferred Stock | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets | ||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | ||||||
| Common Stock Shares Issued | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Shares Outstanding | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBespoke Extracts, Inc. (BSPK) — SEC Financial Statements & Analysis
Bespoke Extracts, Inc. (BSPK) is a pharmaceutical preparations company, incorporated in NV. Bespoke Extracts, Inc. trades on OTC as: BSPK. Bespoke Extracts, Inc. (BSPK)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12. Based on that filing, Bespoke Extracts, Inc. carries a market cap of $3.04M, a P/E ratio of -3.62x, a P/B ratio of -1.17x, a P/S ratio of 2.32x, an enterprise value of $3.55M, and an EV/EBITDA multiple of -4.60x. On profitability, it posts a gross margin of 43.74%, an operating margin of -60.10%, a net margin of -64.22%, a Return on Equity (ROE) of 34.11%, and a Return on Assets (ROA) of -265.14%. Per share, it reports EPS of $-0.07, diluted EPS of $-0.07, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 59.79% year-over-year, net income growth of -42.35% year-over-year, and EPS growth of -45.50% year-over-year. On the balance sheet, it maintains a current ratio of 0.11x, a quick ratio of 0.06x, working capital of $-1.68M, a debt-to-equity ratio of -1.11x, a debt ratio of 9.78, an interest coverage ratio of -16.75x, free cash flow of $-363.64K (TTM), and net debt of $512.45K. Figures sourced from SEC EDGAR.
- Market Cap
- $3.04M
- P/E TTM
- -3.62x
- EPS TTM
- $-0.07
- P/B TTM
- -1.17x
- ROE TTM
- 34.11%
- ROA TTM
- -265.14%
- Debt To Equity
- -1.11x
- Free Cash Flow TTM
- $-363.64K
- Net Revenue TTM Growth 1Y
- 59.79%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Bespoke Extracts, Inc. in?
Bespoke Extracts, Inc. (BSPK) operates in the Pharmaceutical Preparations industry.
What exchange does BSPK trade on?
Bespoke Extracts, Inc. (BSPK) trades on the OTC.
Where is Bespoke Extracts, Inc. incorporated?
Bespoke Extracts, Inc. is incorporated in NV.
When was Bespoke Extracts, Inc. (BSPK)'s most recent SEC filing?
Bespoke Extracts, Inc. (BSPK)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12.
What is BSPK's market cap?
Bespoke Extracts, Inc. (BSPK) has a market capitalization of $3.04M as of 2025-09-30.
What is BSPK's EPS (earnings per share)?
Bespoke Extracts, Inc. (BSPK)'s trailing twelve month EPS is $-0.07 as of 2025-09-30.
What is BSPK's ROE (return on equity)?
Bespoke Extracts, Inc. (BSPK)'s trailing twelve month Return on Equity (ROE) is 34.11% as of 2025-09-30.
What is BSPK's ROA (return on assets)?
Bespoke Extracts, Inc. (BSPK)'s trailing twelve month Return on Assets (ROA) is -265.14% as of 2025-09-30.
What is BSPK's EV/EBITDA?
Bespoke Extracts, Inc. (BSPK)'s trailing twelve month EV/EBITDA is -4.60x as of 2025-09-30.

